N.Y. Education Law Section 6830
Standardized patient-centered data elements

1.

The commissioner shall develop rules and regulations requiring standardized patient-centered data elements consistent with existing technology and equipment to be used on all prescription medicine dispensed to patients in this state.

2.

When developing the requirements for patient-centered data elements on prescription drug labels, the commissioner shall consider:

(a)

medical literacy research that identifies factors that improve understandability of labels and promotes increased compliance with a drug’s intended use;

(b)

factors that improve the clarity of directions for use;

(c)

font types and sizes;

(d)

inclusion of only patient-centered information; and

(e)

the needs of special populations. To ensure public input, the commissioner shall solicit input from the state board of pharmacy and the state board of medicine, consumer groups, advocates for special populations, pharmacists, physicians, other health care professionals authorized to prescribe, and other interested parties.

Source: Section 6830 — Standardized patient-centered data elements, https://www.­nysenate.­gov/legislation/laws/EDN/6830 (updated Sep. 22, 2014; accessed Dec. 21, 2024).

6800
Introduction 6801
Definition of practice of pharmacy 6801‑A
Collaborative drug therapy management demonstration program 6802
Definitions 6803
Practice of pharmacy and use of title “pharmacist” 6804
State board of pharmacy 6805
Requirements for a professional license 6806
Limited permits 6807
Exempt persons 6808
Registering and operating establishments 6808‑A
Identification of Pharmacists 6808‑B
Registration of nonresident establishments 6809
Shared pharmacy services 6810
Prescriptions 6811
Misdemeanors 6811‑A
Certain drugs to be clearly marked or labeled 6811‑B
Door-to-door distribution of drugs prohibited 6811‑C
Patient notification of recalled drugs 6812
Special provisions 6813
Seizure: 1 6814
Records of shipment 6815
Adulterating, misbranding and substituting 6816
Omitting to label drugs, or labeling them wrongly 6816‑A
When substitution is required 6817
New drugs 6818
Adulterated and misbranded cosmetics 6818‑A
Cosmetic samples 6819
Regulations making exceptions 6820
Certification of coal-tar colors for drugs and cosmetics 6821
Poison schedules 6822
Examinations and investigations 6823
Factory inspection 6824
Injunction proceedings 6825
Proof required in prosecution for certain violations 6826
Drug retail price lists 6826‑A
Reducing certain copayments 6827
Mandatory continuing education 6828
Certificates of administration 6829
Interpretation and translation requirements for prescription drugs and standardized medication labeling 6830
Standardized patient-centered data elements 6831
Special provisions relating to outsourcing facilities 6832
Limitations on assistance of an unlicensed person
Green check means up to date. Up to date

Accessed:
Dec. 21, 2024

Last modified:
Sep. 22, 2014

§ 6830’s source at nysenate​.gov

Link Style